Pfizer starts Omicron-specific COVID-19 vaccine trial
The Hindu
The trial will involve 1,420 people aged 18-55.
Pfizer and its partner BioNTech have begun enrolment for a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine in adults aged up to 55, the companies said in a statement on January 25.
Pfizer’s CEO Albert Bourla has previously said that the pharmaceutical giant could be ready to file for regulatory approval of the shot by March.
Malaysia imposes anti-dumping duties on plastic imports from China, Indonesia
New study links fluoride in water to lower IQ in children, sparking debate over safety and benefits.
Discover the significance of C. elegans in biological research, from Nobel Prize-winning discoveries to insights into gene expression control.
Earthquake in Tibetan China and Nepal, with 95 dead, 130 injured, and significant spiritual and environmental implications.
2024's record-breaking temperatures increase pressure on policymakers to address climate change as scientists warn of faster-than-expected global warming impacts.
Unlocking ancient genetic secrets through prehistoric burials, mass graves, and war graves worldwide reveals population dynamics and migrations.
Here are the latest news and big news to follow today
Discover the beauty of Indian craftsmanship at Dastkar Bazaar chennai with over 110 artisans showcasing diverse traditional crafts.
Explainer on why Russians are celebrating Christmas on January 7
These are, of course, all worthy and wonderful resolutions. But I gave up smoking years ago, don’t eat red meat now and wake up early anyway. Maturity is that time in your life when you can make no more new year resolutions. Not because you are perfect and have no bad habits, but because you’d like to keep the remaining bad habits, thank you very much.
Discover the "dinosaur highway" in an Oxfordshire limestone quarry with over 200 footprints from the Jurassic period.